Shire, BBG make pipeline plays

Both Shire (LSE:SHP; SHPGY) and British Biotech (LSE:BBG; BBIOY) made in-licensing moves on Wednesday. SHP licensed from CeNeS (LSE:CEN) a research program focused

Read the full 237 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE